期刊文献+

D-二聚体水平测定在系统性红斑狼疮中的临床意义 被引量:8

Clinical Significance of Assessment of D-dimer in SLE Patient
下载PDF
导出
摘要 目的了解系统性红斑狼疮(SLE)患者外周血中D-二聚体的水平及其临床价值。方法用免疫比浊法测定50例SLE患者血浆D-二聚体水平,研究其与SLE的疾病活动及临床表现的关系。结果 (1)SLE患者血浆D-二聚体水平较正常组显著增高(P<0.001);(2)与D-二聚体水平正常组SLE患者相比,D-二聚体水平升高组SLE患者的SLEDAI积分明显升高(P<0.05),且D-二聚体水平与SLEDAI积分呈显著正相关(r=0.682,P<0.01);(3)抗心磷脂抗体阳性患者与抗心磷脂抗体阴性患者的血浆D-二聚体水平无显著差异(P>0.05),但继发抗磷脂综合征患者血浆D-二聚体水平高于无继发抗磷脂综合征的SLE患者(t=2.157,P=0.03);(4)狼疮肾炎患者血浆D-二聚体水平高于无狼疮肾炎患者(P<0.05)。结论 SLE患者检测血浆D-二聚体,有助于了解SLE疾病的活动性。 Objective To study the clinical significance of plasma D-dimer in patients with systemic lupus erythematosus(SLE).Methods The levels of plasma D-dimer in 50 SLE patients were measured by immunoturbidimetry.Results(1)The levels of D-dimer in SLE patients were significantly higher than those in the controls(P0.001).(2)Compared with SLE patients who have the normal levels of D-dimer,the SLE patients with high levels of D-dimer have a significantly higher SLEDAI scores(P0.05),and the levels were showed a significant positive correlation with SLEDAI scores(r=0.682,P0.01).(3)There was no significant difference on levels of D-dimer between the SLE patients with different levels of anticardiolipin antibodies(P0.05),but the levels of plasma D-dimer in SLE with secondary anti-phospholipid antibody(APS) were obviously higher than that in SLE without secondary APS(t=2.157,P=0.03).(4)The levels of plasma D-dimer in SLE with lupus nephritis(LN) were obviously higher than that in SLE without LN(P0.05).Conclusion Levels of plasma D-dimer in SLE patients might be valuable for assessment of disease activity.
作者 张娟
出处 《黑龙江医学》 2011年第8期561-563,共3页 Heilongjiang Medical Journal
关键词 系统性红斑狼疮 D-二聚体 抗心磷脂抗体 狼疮肾炎 Systemic lupus erythematosus D-dimer Anticardiolipin antibody Lupus nephritis
  • 相关文献

参考文献4

二级参考文献23

  • 1姜学义,峰下哲,韩春雷,杨学莉,汪整辉,寇丽筠,王黎曼,杨杰.系统性红斑狼疮患者纤溶功能测定[J].中华皮肤科杂志,1995,28(4):207-209. 被引量:5
  • 2朱铁楠 潘家琦.D-二聚体在血栓栓塞疾病中的应用[J].协和内科临床,2001,2(5):25-25. 被引量:3
  • 3陈飞 张金黎 李明 等.D-二聚体在肾脏疾病中的临床研究[J].中华肾脏病杂志,1998,14(1):14-14. 被引量:7
  • 4Tan EM, Cone AS, Fries JF ,et al. The 1982 revised Criteria for the classification of lupus erythermatosus [ J ]. Arthritis Rheum, 1982,25 ( 11 ) : 1271-1275. 被引量:1
  • 5董怡.系统性红斑狼疮[M].北京:人民卫生出版社,2000:892-898. 被引量:1
  • 6Ishizaki T, Katsumata K, Tsuchida A, et al. Etodolac, a selective cyclooxygenase-colorectal cancer ceils via the suppression [J] 2006,17(2) :357. 被引量:1
  • 7Esmon CT. Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? [ J]. Blood,2000,95 (2) :113-115. 被引量:1
  • 8Salazar paramo M, Garciadela To, Fritzler M J, et al. Anti-bodies to fibrin-bound tissue-type plasm inogen activator in systemic lupus erythematusus are associated with Raynaud's phenome-nonand thrombosis [ J ]. Lupus, 1996,5 ( 4 ) : 275 -278. 被引量:1
  • 9Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus diseaseactivity using molecular markers of hemostasis.Arthritis Rheum,1996 Feb,39(2)∶287-291. 被引量:1
  • 10Salazar paramo M, Garcia de la Torre l, Fritzler Mj,et al.Antibodies tofibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus areassociated with Raynaud's phenomenon and thrombosis. Lupus, 1996 Aug, 5(4)∶275-278. 被引量:1

共引文献134

同被引文献40

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部